A better investor than I told me about this company. Hemacare (HEMA) is a $3.5M market cap company that has transformed their business in the darkness, outside the view of Wall Street. HEMA started life decades ago as a blood bank. Realizing the limitations of that business, leadership started down a new path several years ago. They have refocused the company and are experiencing strong growth in the bioresearch space. They are valued as if they are dying and herein lies the opportunity. The investment community does not know of their transformation...yet...